疑难病杂志
疑難病雜誌
의난병잡지
JOURNAL OF DIFFICULT AND COMPLICATED CASES
2014年
2期
136-138,142
,共4页
张宸豪%臧艳静%李文贵%陈利明%李鸿萱%李小玲%韩海青%范银平
張宸豪%臧豔靜%李文貴%陳利明%李鴻萱%李小玲%韓海青%範銀平
장신호%장염정%리문귀%진리명%리홍훤%리소령%한해청%범은평
乌灵胶囊%预防%脑梗死%抑郁%认知障碍%疗效
烏靈膠囊%預防%腦梗死%抑鬱%認知障礙%療效
오령효낭%예방%뇌경사%억욱%인지장애%료효
Wuling capsule%Prevention%Cerebral infarction depression%Cognitive%Disorders%Efficacy
目的:观察乌灵胶囊( WL)预防脑梗死后抑郁和认知障碍患者临床疗效。方法脑梗死患者435例随机分为WL组和对照组,在常规治疗基础上,WL组口服WL胶囊3粒,每日3次;对照组口服安慰剂胶囊3粒,每日3次,疗程均6周。分别于治疗前及治疗后1、2、4、6周末及3月末以HAMD、MoCA、NIHSS评分进行评定,并观察抑郁发生情况。结果(1)抑郁发病率:治疗2、4周末,WL组抑郁发病率均低于对照组,但差异无统计学意义( P >0构.05),治疗6周末及3个月末,WL组抑郁发病率均低于对照组,且差异有统计学意义( P <0.05)。(2)HAMD评分:2组治疗后均较治疗前升高( P <0.05),且WL组2、4、6周末及3个月末均低于对照组( P <0.05)。(3)NIHSS评分:除第1周末外,2组治疗后NIHSS评分均较治疗前下降( P <0.05),且WL组均优于对照组( P <0.05)。(4)Mo-CA评分:2组治疗后4、5周末及3个月末MoCA评分均较治疗前升高( P <0.05),且WL组均高于对照组( P <0.05)。(5)不良反应:2组均未发生严重不良反应。结论乌灵胶囊防治脑梗死后抑郁及认知障碍疗效明显。
目的:觀察烏靈膠囊( WL)預防腦梗死後抑鬱和認知障礙患者臨床療效。方法腦梗死患者435例隨機分為WL組和對照組,在常規治療基礎上,WL組口服WL膠囊3粒,每日3次;對照組口服安慰劑膠囊3粒,每日3次,療程均6週。分彆于治療前及治療後1、2、4、6週末及3月末以HAMD、MoCA、NIHSS評分進行評定,併觀察抑鬱髮生情況。結果(1)抑鬱髮病率:治療2、4週末,WL組抑鬱髮病率均低于對照組,但差異無統計學意義( P >0構.05),治療6週末及3箇月末,WL組抑鬱髮病率均低于對照組,且差異有統計學意義( P <0.05)。(2)HAMD評分:2組治療後均較治療前升高( P <0.05),且WL組2、4、6週末及3箇月末均低于對照組( P <0.05)。(3)NIHSS評分:除第1週末外,2組治療後NIHSS評分均較治療前下降( P <0.05),且WL組均優于對照組( P <0.05)。(4)Mo-CA評分:2組治療後4、5週末及3箇月末MoCA評分均較治療前升高( P <0.05),且WL組均高于對照組( P <0.05)。(5)不良反應:2組均未髮生嚴重不良反應。結論烏靈膠囊防治腦梗死後抑鬱及認知障礙療效明顯。
목적:관찰오령효낭( WL)예방뇌경사후억욱화인지장애환자림상료효。방법뇌경사환자435례수궤분위WL조화대조조,재상규치료기출상,WL조구복WL효낭3립,매일3차;대조조구복안위제효낭3립,매일3차,료정균6주。분별우치료전급치료후1、2、4、6주말급3월말이HAMD、MoCA、NIHSS평분진행평정,병관찰억욱발생정황。결과(1)억욱발병솔:치료2、4주말,WL조억욱발병솔균저우대조조,단차이무통계학의의( P >0구.05),치료6주말급3개월말,WL조억욱발병솔균저우대조조,차차이유통계학의의( P <0.05)。(2)HAMD평분:2조치료후균교치료전승고( P <0.05),차WL조2、4、6주말급3개월말균저우대조조( P <0.05)。(3)NIHSS평분:제제1주말외,2조치료후NIHSS평분균교치료전하강( P <0.05),차WL조균우우대조조( P <0.05)。(4)Mo-CA평분:2조치료후4、5주말급3개월말MoCA평분균교치료전승고( P <0.05),차WL조균고우대조조( P <0.05)。(5)불량반응:2조균미발생엄중불량반응。결론오령효낭방치뇌경사후억욱급인지장애료효명현。
Objective To observe the curative effects of Wuling capsule ( WL) in preventing depression after cere-bral infarction ( DCI) and cognitive disorder .Methods Cerebral infarction 435 cases were randomly divided into two groups ( WL group and control group ) , based on the conventional treatment , WL group received oral WL capsules , 3 times a day;the control group was treated with placebo capsules , 3 times daily for all six weeks .Before and after treatment with 1st, 2nd, 4th, 6th weekends and at the end of 3 months, HAMD, MoCA, NIHSS score were assessed and observed the occurrence of depression .Results (1) The incidence of depression:Treatment at 2nd, 4th weekend, incidence rates of depression in WL group were lower than the control group , but the difference was not statistically significant ( P >0.05), and 6 weeks to 3 months after treatment , incidence rates of depression in WL group lower than the control group , and the difference was statisti-cally significant ( P <0.05).(2) HAMD score:2 groups after treatment increased than before treatment ( P <0.05), and in the WL group, at 2nd, 4th, 6th weekend and at the end of 3 months, the score were lower than the control group ( P <0.05).(3) NIHSS score:In addition to the first weekend , after treatment, the two groups'NIHSS score decreased than be-fore treatment ( P <0.05), and WL groups were better than the control group ( P <0.05).(4) MoCA Rating:after treat-ment, at 4th, 5th weekend and at the end of 3 months, the 2 groups'MoCA scores were elevated before treatment ( P <0.05), and WL groups were higher ( P <0.05).(5) Adverse reactions: two groups were not found serious adverse reac-tions.Conclusion It showed obviously effect of Wuling capsule on preventing DCI and neurological deficit .